Sleep-Disordered Breathing in Older Adults: Clinical Insights and Evidence-Based Management

Abstract

Sleep-disordered breathing (SDB) encompasses a spectrum of respiratory disturbances during sleep, notably obstructive sleep apnea (OSA) and central sleep apnea (CSA), and is increasingly recognized as a significant health concern in the older adult population. This review synthesizes current knowledge regarding the epidemiology, mechanisms, risk factors, clinical presentation, diagnostic strategies, management options, and guideline-based recommendations for SDB in older adults. Special emphasis is placed on age-specific pathophysiological changes, diagnostic challenges, treatment adaptation, and recent advances in therapeutic approaches. The article aims to provide clinicians with practical, evidence-based guidance for optimizing care in this vulnerable population.

Introduction

Sleep-disordered breathing represents a group of conditions characterized by abnormal respiratory patterns or insufficient ventilation during sleep, leading to intermittent hypoxia, sleep fragmentation, and subsequent multisystem consequences. With advancing age, the prevalence, clinical complexity, and health impact of SDB increase due to various anatomical, physiological, and comorbid factors. Understanding the unique features of SDB in older adults is crucial for timely recognition, accurate diagnosis, and effective management, minimizing morbidity and improving quality of life.

Epidemiology / Disease Burden

Epidemiological data demonstrate a marked rise in the prevalence of SDB, particularly OSA, with advancing age. Population-based studies estimate that up to 30-60% of adults over 65 years exhibit some degree of SDB, often with higher apnea-hypopnea indices (AHI) compared to younger cohorts. However, underdiagnosis remains common, owing to atypical symptomatology and overlapping comorbidities. The morbidity burden is substantial, with associations to cardiovascular disease, metabolic dysfunction, neurocognitive impairment, and increased healthcare utilization. SDB also contributes to frailty, falls, and diminished daily functioning in older adults, further underscoring its clinical significance.

Pathophysiology

The pathophysiology of SDB in older adults is multifactorial and includes both anatomical and functional changes. Age-related reductions in upper airway muscle tone, increased pharyngeal collapsibility, and deposition of parapharyngeal fat predispose to OSA. Central mechanisms, such as altered chemosensitivity and unstable ventilatory control, contribute to CSA, which is more prevalent in the elderly. Comorbidities including heart failure, cerebrovascular disease, and neurodegeneration further modulate SDB risk. The cumulative effect is a heightened vulnerability to apneas, hypopneas, and their sequelae, with variability in phenotype and severity.

Risk Factors

Established risk factors for SDB in older adults include male sex, obesity, craniofacial abnormalities, congestive heart failure, atrial fibrillation, chronic kidney disease, and use of sedative medications. Age-related changes in sleep architecture, reduced arousal response, and polypharmacy also modulate risk. Notably, non-obese SDB phenotypes are increasingly recognized in the elderly, highlighting the need for vigilance beyond traditional risk profiles. Genetic predisposition and family history play a lesser but contributory role.

Clinical Features

The clinical presentation of SDB in older adults often deviates from classic symptoms. While loud snoring, witnessed apneas, and excessive daytime sleepiness remain important, nonspecific manifestations such as cognitive decline, mood disturbance, nocturia, morning headaches, and impaired functional status are prevalent. Older adults may underreport sleepiness, attributing symptoms to aging or comorbidities. These subtleties necessitate a high index of suspicion, especially in the context of unexplained neuropsychiatric or cardiovascular deterioration.

Diagnosis

Diagnosis of SDB relies on polysomnography (PSG), which remains the gold standard, though home sleep apnea testing (HSAT) is increasingly utilized. In older adults, diagnostic accuracy may be challenged by sleep fragmentation, comorbid insomnia, and atypical respiratory events. Thorough clinical assessment, including validated screening questionnaires (e.g., STOP-BANG, Epworth Sleepiness Scale), should be coupled with objective sleep studies to capture the full spectrum of SDB and its impact. Evaluation of comorbidities and medication review are integral to the diagnostic process.

Treatment & Management

Continuous positive airway pressure (CPAP) therapy is the cornerstone of SDB management and is effective in reducing AHI, improving symptoms, and mitigating cardiovascular risk, even in older adults. Treatment adherence can be challenging due to cognitive impairment, dexterity issues, and mask intolerance; thus, individualized education, device adaptation, and caregiver involvement are essential. Alternative therapies include bilevel positive airway pressure (BiPAP) for CSA or complex cases, oral appliances, positional therapy, and upper airway surgery in selected patients. Adjunctive strategies focus on weight management, optimization of comorbidities, and reduction of sedative use.

Recent Advances / Emerging Therapies

Recent advances in SDB management for older adults encompass novel positive airway pressure modalities (e.g., auto-titrating devices), adaptive servo-ventilation for CSA, and hypoglossal nerve stimulation for OSA refractory to CPAP. Telemedicine and remote monitoring have enhanced adherence and follow-up in this population. Pharmacological interventions targeting ventilatory control instability are under investigation. Research continues into phenotype-specific approaches and the impact of SDB treatment on cognitive outcomes and frailty in the aging population.

Guideline Recommendations

Contemporary guidelines from organizations such as the American Academy of Sleep Medicine and the European Respiratory Society emphasize the importance of systematic screening, diagnostic confirmation via PSG or HSAT, and shared decision-making for therapy selection in older adults. CPAP remains first-line for moderate-to-severe OSA, with consideration of comorbidities and patient preference in management planning. Ongoing monitoring for efficacy, adherence, and side effects is advocated. Guidelines also address the nuanced approach required for CSA and the role of multidisciplinary care in optimizing outcomes.

Conclusion

Sleep-disordered breathing in older adults is a prevalent and clinically consequential condition that warrants heightened recognition and tailored management. Age-specific pathophysiological changes, diverse risk profiles, and atypical presentations necessitate a nuanced diagnostic and therapeutic approach. Evidence-based interventions, supported by recent advances and guideline recommendations, can significantly improve health outcomes, functional status, and quality of life in this growing population. Ongoing research and multidisciplinary collaboration remain vital to addressing the evolving challenges of SDB in aging individuals.